Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population-Reference-Cited by-同舟云学术

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population

Published:2014-10-16 Issue:1 Volume:1 Page:
ISSN:2054-345X
Container-title:Human Genome Variation
language:en
Short-container-title:Hum Genome Var

Author:

Felix Gabriela ES,Abe-Sandes Camila,Machado-Lopes Taísa MB,Bomfim Thaís F,Guindalini Rodrigo Santa Cruz,Santos Vanessa Catarine SAR,Meyer Lorena,Oliveira Polyanna C,Cláudio Neiva João,Meyer Roberto,Romeo Maura,Betânia Toralles Maria,Nascimento Ivana,Abe-Sandes Kiyoko

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Biochemistry

Link

http://www.nature.com/articles/hgv201412.pdf

Reference59 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global Cancer Statistics. CA Cancer J Clin 2011; 61: 69–90.

2. Smith EC . An overview of hereditary breast and ovarian cancer syndrome. J Midwifery Womens Health 2012; 57: 577–584.

3. Apoustolou P, Fostira F . Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int 2013; 2013: 74318.

4. Achatz MIW, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM et al. The TP53 mutation, R337H, is associated with Li–Fraumeni and Li–Fraumeni-like syndromes in Brazilian families. Cancer Lett 2007; 245: 96–102.

5. Allinen M M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R . Mutation analysis of the CHEK2 gene in families with hereditary breast cancer. Br J Cancer 2001; 85: 209–212.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases;Breast Cancer Research and Treatment;2024-06-14

2. Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System;BMC Cancer;2024-04-19

3. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario;European Journal of Medical Research;2024-03-20

4. Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service;Scientific Reports;2022-11-03

5. What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?;Frontiers in Oncology;2022-09-05